DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Bruix J, Takayama T, Mazzaferro V. et al.
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Oncol 2015;
16: 1344-1354
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.